Sorry for interrupting, this website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Learn more
Accept & Close

Analgesics - US - June 2016

"The analgesics market has experienced modest growth in recent years. The majority of consumers turn to some form of OTC (over-the-counter) analgesic to treat pain, with internal analgesics remaining the dominate choice for pain relief, though external analgesics continue to experience faster growth. Looking forward, consumers’ need for pain treatments is not expected to change, and a preference for familiar brands will remain; however, interest is growing for natural ingredients and easy-to-use formats."

- Marissa Gilbert, Health and Wellness Analyst 

This report discusses the following key topics:

  • Feminine pain reliever sales descend further
  • Internal analgesic purchases are automatic; consumers are not seeking advice
  • Perceptions of external analgesics are soft

For the purposes of this Report, Mintel has segmented the analgesics market as follows:

  • OTC internal analgesics - Acetaminophen, aspirin, ibuprofen, naproxen sodium, magnesium salicylate
  • OTC external analgesics - Rubs – such as topical creams/sprays and patches/wraps – with heating/cooling properties

What you get

What's included

Why buy from us?

Succeed

Our reports will provide you with market data, consumer research and competitive intelligence to succeed in your market.

Instant Access

Buy now and you'll have instant access to the information you need to make the right decisions.

Opportunities

Find out what's next in the markets that matter to you: where opportunities lie and what challenges you will face.

Trusted

A business Superbrand, Mintel is a source you can trust. We have been defining and refining the Market Intelligence mix since 1972.

Table of contents

  1. Overview

    • What you need to know
      • Definition
      • Executive Summary

        • The issues
          • Feminine pain reliever sales descend further
            • Figure 1: Percent change in MULO sales of internal analgesics, by subsegments, rolling 52-weeks 2015 and 2016
          • Internal analgesic purchases are automatic; consumers are not seeking advice
            • Figure 2: Purchase factors when choosing an internal pain reliever, March 2016
          • Perceptions of external analgesics are soft
            • Figure 3: External analgesic format perceptions, March 2016
          • The opportunities
            • Opportunity to expand usage among older adults
              • Figure 4: Heating/cooling wraps or patches use, by age, March 2016
            • Increase first-use of external analgesics in treatment steps
              • Figure 5: Used first in pain relieving treatment plan, March 2016
            • Stress-reducing pain relievers could offer relaxation and relief
              • Figure 6: Sources of pain, March 2016
            • What it means
            • The Market – What You Need to Know

              • The analgesics market experiences modest growth
                • Internal analgesics dominate the market; yet external growing quicker
                  • Alternative pain relieving options likely impact OTC analgesics sales
                    • Stress and age factor into the need for pain relief
                    • Market Size and Forecast

                      • Modest market growth continues
                        • Figure 7: Total US sales and fan chart forecast of OTC analgesics, at current prices, 2011-21
                        • Figure 8: Total US sales and forecast of OTC analgesics, at current prices, 2011-21
                    • Market Breakdown

                      • Internal analgesics lead the market; yet external growing more rapidly
                        • Figure 9: Market share of OTC analgesics sales, by segment, 2014 and 2016
                        • Figure 10: Percent change in OTC analgesics sales, by segment, at current prices, 2012-16
                      • Other retail channels remain the go-to for analgesics
                        • Figure 11: Total US retail sales of analgesics, by channel, at current prices, 2014 and 2016
                    • Market Perspective

                      • Muscle/body devices protect against pain
                        • Figure 12: MULO sales of muscle/body support devices, by leading companies and brands, rolling 52-weeks 2015 and 2016
                      • TENS devices can offer at-home relief
                        • Figure 13: MULO sales of electrotherapy devices, by leading companies and brands, rolling 52-weeks 2015 and 2016
                    • Market Factors

                      • Chronic stress can lead to pain
                        • Age factors in how pain is treated; shifting dynamics have market impact
                          • Figure 14: US population aged 18 or older, by age, 2011-21
                      • Key Players – What You Need to Know

                        • High selling internal analgesic brands sustain the analgesics market
                          • Diversified external analgesics segment and iconic internal brands succeeding
                            • Sales decline for niche pain category; overmedicating on alert
                              • External patches, wearable devices, and retro brands are on the horizon
                              • Manufacturer Sales of Analgesics

                                • Top companies in the market driven by internal analgesic sales
                                  • Figure 15: Manufacturer sales of analgesics, 2015 and 2016
                              • What’s Working?

                                • Several players in the external segment lifting sales in the overall market
                                    • Figure 16: MULO sales of external analgesics by leading companies and brands, rolling 52-weeks 2015 and 2016
                                  • J&J sales boost a slow growing internal segment
                                    • Figure 17: MULO sales of internal analgesics, by leading companies and brands, rolling 52-weeks 2015 and 2016
                                • What’s Struggling?

                                  • Sales of feminine internal pain relievers continue downward
                                    • Figure 18: MULO sales of feminine pain relievers, by select companies and brands, rolling 52-weeks 2015 and 2016
                                  • Overmedicating for pain relief is under scrutiny
                                  • What’s Next?

                                    • BLUE-EMU launches first lidocaine patch
                                      • Traditionally internal medication administered via a skin patch
                                        • More wearable TENS devices available to consumers; Quell wins award
                                          • What’s old could be new again
                                          • The Consumer – What You Need to Know

                                            • Pain is common, so is use of pain relieving medications
                                              • A medication is consumers’ first treatment choice to relieve pain
                                                • The causes of pain are diverse; stress leads the way
                                                  • Consumers purchase OTC internal remedies based on experience
                                                    • OTC external analgesics elicit stronger purchasing requirements
                                                      • Internal analgesics garner stronger perceptions than external
                                                        • Single dosages, guidance, natural and migraine patches appeal to some consumers
                                                        • Pain Reliever Use

                                                            • Experiencing some pain and using a treatment is almost certain
                                                              • Figure 19: Pain reliever use, March 2016
                                                            • Internal analgesics used most; type used varies by gender and age
                                                              • Figure 20: Internal pain reliever use, by gender and age, March 2016
                                                            • More than one third of adults use an external remedy
                                                              • Figure 21: External pain reliever use, by age, March 2016
                                                              • Figure 22: Cross of external pain reliever use by internal remedies, March 2016
                                                            • White and Hispanic adults most likely to use an analgesic
                                                              • Figure 23: Pain reliever use, by race and Hispanic origin, March 2016
                                                          • Treatment Plan for Pain Relief

                                                              • When pain strikes, consumers turn to medications for relief
                                                                • Figure 24: Treatment plan for pain relief, March 2016
                                                              • Consumers specifically treat with an OTC internal analgesic first
                                                                • Figure 25: Use first in pain relieving treatment plan, March 2016
                                                                • Figure 26: Use of an internal OTC first in pain relieving treatment plan, by age, race, and Hispanic origin, March 2016
                                                              • Resting is also a key to treatment; particularly among young adults
                                                                • Figure 27: Use rest in pain relieving treatment plan, by 1st, 2nd, 3rd and any 1st/2nd/3rd by gender and age, March 2016
                                                              • Asian adults turning to nonmedical treatments first; Black adults resting
                                                                • Figure 28: Use first in pain relieving treatment plan, by race and Hispanic origin, March 2016
                                                            • Sources of Pain

                                                                • Stress is considered the leading source of pain
                                                                  • Figure 29: Sources of pain, March 2016
                                                                • Older adults more likely to associate age as the source of body pain
                                                                  • Figure 30: Age as source of pain, by age, March 2016
                                                                • Health ailments are also a driving force for pain
                                                                  • Figure 31: Medical issues as source of pain, by age, March 2016
                                                                • Perceptions of pain caused by physical activity varies by race and ethnicity
                                                                  • Figure 32: Activity as source of pain, by race and Hispanic origin, March 2016
                                                              • Choosing an Internal OTC Pain Reliever

                                                                  • Internal pain relievers are dependable choice
                                                                    • Figure 33: Purchase factors when choosing an internal pain reliever, March 2016
                                                                  • Price and brand are more important to men
                                                                    • Figure 34: Select purchase factors when choosing an internal pain reliever, by gender, March 2016
                                                                  • White adults trust what has worked; while Black adults seek fast acting
                                                                    • Figure 35: Select purchase factors when choosing an internal pain reliever, by race and Hispanic origin, March 2016
                                                                • Choosing an External OTC Pain Reliever

                                                                    • External OTC pain reliever users have stronger purchasing requirements
                                                                      • Figure 36: Purchase factors when choosing an external pain reliever, March 2016
                                                                    • Consumers seek out information about external analgesics
                                                                      • Figure 37: Impact of a recommendation, product reviews, and commercial when choosing an external pain reliever, by gender and age, race and Hispanic origin, and generation, March 2016
                                                                  • Format Perceptions

                                                                      • Perceptions of internal analgesics more positive than external
                                                                        • Figure 38: Format perceptions, March 2016
                                                                      • Consumers’ familiarity with tablets drives up perceptions
                                                                        • Figure 39: Internal analgesic format perceptions, March 2016
                                                                      • External formats garner soft perceptions; barriers to use stand out
                                                                        • Figure 40: External analgesic format perceptions, March 2016
                                                                    • Interest in Innovations

                                                                        • More than one third of adults are interested in single-dose medications
                                                                          • Figure 41: Interest in single-dose medications, by age, March 2016
                                                                        • Some adults would like more guidance in finding pain relief
                                                                          • Figure 42: Interest in advice and technology innovations, by age, March 2016
                                                                        • Natural remedies have noteworthy appeal
                                                                          • Figure 43: Interest in natural ingredients, Arnica, and aromatherapy/essential oils, by age, March 2016
                                                                        • Migraine/headache patch to relieve pain appeals to young women
                                                                          • Figure 44: Interest in external patch for migraine/headaches, by gender and age, March 2016
                                                                          • Figure 45: Experience migraine headaches, by gender, Fall 2015 NHCS Adult Study 12-month
                                                                      • Appendix – Data Sources and Abbreviations

                                                                        • Data sources
                                                                          • Sales data
                                                                            • Fan chart forecast
                                                                              • Consumer survey data
                                                                                • Abbreviations and terms
                                                                                  • Abbreviations
                                                                                    • Terms
                                                                                    • Appendix – Market

                                                                                        • Figure 46: Total US sales and forecast of OTC analgesics, at inflation-adjusted prices, 2011-21
                                                                                        • Figure 47: Total US retail sales of analgesics, by channel, at current prices, 2011-16
                                                                                        • Figure 48: Total US retail sales and forecast of analgesics, by segment, at current prices, 2011-21
                                                                                        • Figure 49: Total US retail sales of analgesics, by segment, at current prices, 2014 and 2016
                                                                                        • Figure 50: MULO sales of muscle/body support devices, by leading companies and brands, rolling 52-weeks 2015 and 2016
                                                                                        • Figure 51: MULO sales of electrotherapy devices, by leading companies and brands, rolling 52-weeks 2015 and 2016
                                                                                    • Appendix – Key Players

                                                                                        • Figure 52: MULO sales of internal analgesics, by leading companies and brands, rolling 52-weeks 2015 and 2016
                                                                                        • Figure 53: MULO sales of external analgesics by leading companies and brands, rolling 52-weeks 2015 and 2016
                                                                                        • Figure 54: Percentage of adults agreeing with statement – Any agree (net)*, 2011-15

                                                                                    Companies Covered

                                                                                    • Walmart Stores (USA)

                                                                                    Analgesics - US - June 2016

                                                                                    £3,174.67 (Excl.Tax)